He believes neither not think there will be any new bids.
– I believe that it is unlikely, he says DI.
The reason it is that the pharmaceutical giant’s share price soared this year and that the opportunities for Pfizer to lower taxes by moving the company’s domicile declined.
Soriot think entire process of bid for Astra Zeneca been harmful when employees, not least in Sweden, alarmed.
No comments:
Post a Comment